Expert consensus on Tongsaimai Tablets/Capsules in treatment of peripheral vascular diseases in clinical practiceChinese Full TextEnglish Full Text (MT)
CAO Ye-min;WANG Yu-zhen;PEI Xiao-hua;YANG Bo-hua;ZHAO Cheng;FANG Yu-dong;QUE Hua-fa;JIANG Yu-feng;XU Xu-ying;XIA Cheng-yong;ZHANG Jian-qiang;HE Chun-hong;MA Li-ren;Shanghai Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine/Shanghai Institute of Integrated Traditional Chinese and Western Medicine and Vascular Diseases;Xiamen Hospital of Beijing University of Chinese Medicine;Dongzhimen Hospital, Beijing University of Chinese Medicine;Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine;Special Medical Center of Strategic Support Force;Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University;Jiangsu Provincial Hospital of Traditional Chinese Medicine;Shijiazhuang Hospital of Traditional Chinese Medicine;Luoyang Hospital of Traditional Chinese Medicine;Pingdingshan Hospital of Traditional Chinese Medicine;
Abstract: Tongsaimai Tablets/Capsules are composed of Lonicerae Japonicae Flos, Angelicae Sinensis Radix, Achyranthis Bidentatae Radix, Codonopsis Radix, Dendrobii Caulis, Astragali Radix, Scrophulariae Radix, and Glycyrrhizae Radix et Rhizoma, and are effective in promoting blood circulation, removing blood stasis, supplementing Qi, and nourishing Yin. It is widely used in the treatment of peripheral vascular diseases. With 40 years of clinical application, it has accumulated substantial research data and application experience. Its good clinical efficacy and pharmacoeconomic benefits in improving the clinical symptoms of peripheral vascular diseases have been confirmed by relevant research. Meanwhile, this drug has also been recommended by many expert consensus, guidelines, and teaching materials, serving as one of the most commonly used Chinese patent medicines in clinical practice. To further improve the understanding of the drug among clinicians and properly guide its clinical medication, the China Association of Chinese Medicine took the lead and organized experts to jointly formulate this expert consensus. Based on the questionnaire survey of clinicians and the systematic review of research literature on Tongsaimai Tablets/Capsules with clinical problems in the PICO framework, the consensus, combined with expert experience, concludes recommendations or consensus suggestions by GRADE system with the optimal evidence available through the nominal group technique. This consensus defines the indications, usage, dosage, course of treatment, medication time, combined medication, and precautions of Tongsaimai Tablets/Capsules in the treatment of peripheral vascular diseases, and explains the safety of its clinical application. It is recommended for clinicians and pharmacists in the peripheral vascular department（vascular surgery）, traditional Chinese medicine surgery（general surgery）, and endocrinology department of hospitals at all levels in China.
- DOI：
10.19540/j.cnki.cjcmm.20211009.501
- Series：
(E) Medicine ＆ Public Health
- Subject：
Traditional Chinese Medicine
- Classification Code：
R259
- Mobile Reading
Read on your phone instantly
Step 1Scan QR Codes
"Mobile CNKI-CNKI Express" App
Step 2Open“CNKI Express”
and click the scan icon in the upper left corner of the homepage.
Step 3
Scan QR Codes
Read this article on your phone.
- HTML
- BETABETAEnglish HTML (MT)
- CAJ Download
- PDF Download
Download the mobile appuse the app to scan this coderead the article.
Tips: Please download CAJViewer to view CAJ format full text.
Download: 640 Page: 6568-6573 Pagecount: 6 Size: 1106K
Citation Network
Related Literature
- Similar Article
- Reader Recommendation
- Associated Author